Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Health Innovation Journal

The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting

As featured in this year's Oliver Wyman Health Innovation Journal, we examine the emerging sparks beginning to define the dimensions of a new healthcare industry.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health and Life Sciences, Oliver Wyman
Former Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

How genetics can help cut treatment costs by getting prevention services to consumers most at risk.

Chief Operating Officer, Color Genomics, Inc

Why healthcare needs the new technology and how investors and innovators can take advantage of the revolution.

Chief Strategy Officer, BCBS of Massachusetts

Insights in your inbox

Subscribe

As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Five steps healthcare leaders can take to help tackle consumers’ most pressing jobs to be done and become truly consumer-centric.

Partner, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare